• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioventus Inc Cl A (NQ: BVS )

    7.170 +0.100 (+1.41%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 327,648
    Open 7.070
    Bid (Size) 7.150 (8)
    Ask (Size) 7.170 (52)
    Prev. Close 7.070
    Today's Range 7.070 - 7.340
    52wk Range 2.850 - 7.385
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Stocks Under $10 With Mammoth Growth Prospects
    Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. 
    Via InvestorPlace
    Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    +36.57%
    +36.57%
    1 Month
    +28.04%
    +28.04%
    3 Month
    +60.04%
    +60.04%
    6 Month
    +49.38%
    +49.38%
    1 Year
    +117.27%
    +117.27%

    More News

    Read More
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    A Preview Of Bioventus's Earnings
    Via Benzinga
    Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
    Via Benzinga
    Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Bioventus Reports First Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 12, 2024
    Via Benzinga
    BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
    From Bioventus, Inc.
    Via GlobeNewswire
    Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
    From Bioventus, Inc.
    Via GlobeNewswire
    BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Bioventus Names Robert Claypoole as President and Chief Executive Officer
    From Bioventus, Inc.
    Via GlobeNewswire
    MedTech Bioventus' Stabilization Sparks Analyst Confidence, Earns Upgrade And Price Target Boost
    Via Benzinga
    Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
    From Bioventus, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.